Express News | Ultragenyx Pharmaceutical Inc : JP Morgan Raises Target Price to $105 From $94
BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $73
Ultragenyx Pharmaceutical: A Strong Buy on Rare Disease Program Progress and Strategic Management
RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy Tag
Ultragenyx Pharmaceutical's Bone Disease Drug Gets FDA's Breakthrough Therapy Designation
Express News | Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (Ux143) in Osteogenesis Imperfecta
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta
Leerink Partners Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $85
Stifel Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $127
BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Announces Target Price $73
Ultragenyx Pharmaceutical Wilson Disease Therapy Study Shows Meaningful Data
Express News | Ultragenyx Pharmaceutical Inc - Ux701 Well Tolerated With No Significant Immunologic Safety Events
Express News | Ultragenyx Pharmaceutical Inc - to Enroll Additional Cohort at Increased Dose in Ux701 Study
Express News | Ultragenyx Pharmaceutical Inc - Reports Meaningful Clinical Activity in Ux701 Gene Therapy Study
Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease
Express News | Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating Ux701 Gene Therapy for the Treatment of Wilson Disease
TD Cowen Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $61
Barclays Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $81
Is Ultragenyx Pharmaceutical (NASDAQ:RARE) A Risky Investment?
Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting